Your partner for clinical manufacturing

CDMO facility for clinical manufacturing

Choosing the right CDMO partner in early phases is the key to successful drug development. Vetter Development Service Chicago facility at Illinois Science + Technology Park in Skokie provides comprehensive clinical manufacturing resources from Preclinical to Phase II including aseptic vial and syringe filling as well as lyophilization.

We believe in the success of your product and can guide you through the entire manufacturing process. With over 35 years of experience and expertise in aseptic fill and finish, Vetter will support you with product development, clinical manufacturing and regulatory approvals. Our state-of-the-art clinical production site will provide you with the highest possible quality for your biologics and pharmaceuticals.

Flexible batch sizes

vials < 1000 up to 15000 Vials
vials < 1000 up to 25000 Syringes

We can fill various batch sizes based on the characteristics of your product. 

Download for more information 

Please accept marketing-cookies to watch this video.
John Moore, Director Global Clinical Business Development at Vetter

 

Our Service Portfolio

  • Take advantage of our ongoing investment in technology and quality and our comprehensive know-how in:
    • Process development
    • Feasibility and stability studies
    • Technical & engineering batches, GMP clinical batches
    • Scale-up for late phase & commercial manufacturing 
    • Regulatory support

Our Approach

  • Facility and processes designed to maximize drug product yield
  • Development streamlined by:
    • Use of disposable materials for time efficiency
    • Compliant with US and European manufacturing standards
    • Proven tech transfer processes from clinical to commercial manufacturing
    • Scalable production

Vetter’s expertise and uncompromising quality has contributed to our success even under our highly aggressive timelines. It has been a pleasure working with the Vetter Teams in Chicago and Germany.

Ron Tetreault, Director CMC, Agenus Inc.

200+

compounds have been filled, many of which have been filled multiple times.

90+

customers with headquarters in 16 different countries.

60%

of our customers have less than 200 employees. Around 40% are medium-sized and large companies.

Clinical filling project scope - major milestones

Step 1: Project kick-off - open communication and exchange of necessary information

Step 2: Customized process development including material requirements and selection of primary packaging material

Step 3: Method transfers, lab qualification and technical runs

Step 4: GMP clinical batch manufacturing

Step 5: Regulatory filing support and clinical batch release

Get in touch

Contact Paulina Broda at infoUS@vetter-pharma.com or +1 (847) 581 6888 to be connected with the right business development professional.

Get in touch